Augmentin Dosage for 9.5kg 18-Month-Old Child
For an 18-month-old child weighing 9.5 kg, give Augmentin syrup 4.5 mL twice daily (using the 400 mg/57 mg per 5 mL formulation) or 3 mL twice daily (using the ES-600 formulation at 600 mg/42.9 mg per 5 mL), depending on infection severity and local resistance patterns.
Standard Dosing Recommendations
The FDA-approved dosing for Augmentin in children depends on the formulation and clinical indication 1:
For Routine Infections (Standard Formulation)
- Dose: 45 mg/kg/day of amoxicillin component divided into 2 doses
- For 9.5 kg child: This equals approximately 213 mg amoxicillin per day
- Using 400 mg/57 mg per 5 mL suspension: Give 4.5 mL twice daily (approximately 190 mg amoxicillin per dose = 380 mg/day total)
For Resistant Infections or Severe Disease (ES-600 Formulation)
- Dose: 90 mg/kg/day of amoxicillin component divided every 12 hours 1
- For 9.5 kg child: This equals 855 mg amoxicillin per day
- Using ES-600 (600 mg/42.9 mg per 5 mL): Give 3.0 mL twice daily (360 mg per dose = 720 mg/day total)
Clinical Context for Dosing Selection
Use standard-dose formulation (45 mg/kg/day) for:
- Uncomplicated respiratory tract infections
- Acute otitis media in fully immunized children
- Areas with low penicillin resistance 2
Use high-dose ES-600 formulation (90 mg/kg/day) for:
- Treatment failure on standard therapy 3
- Regions with high-level penicillin-resistant S. pneumoniae 2
- Severe infections or empyema 2
- Beta-lactamase-producing H. influenzae coverage 3, 2
Important Administration Details
- Give at the start of meals to minimize gastrointestinal side effects and enhance clavulanate absorption 1
- Duration: Typically 5-10 days depending on infection type 1
- Shake suspension well before each dose 1
- Refrigerate after reconstitution; stable for 10 days 1
Critical Caveats
Do not substitute formulations interchangeably - the ES-600 contains different clavulanate ratios (42.9 mg/5 mL) compared to standard suspensions (28.5 or 57 mg/5 mL), making them non-interchangeable 1.
The twice-daily dosing regimen shows equivalent efficacy to three-times-daily dosing with improved compliance (82.8% vs 73.3%) and reduced diarrhea incidence (7.2% vs 10.7%) 4, 5.
For beta-lactamase-producing organisms, amoxicillin-clavulanate provides superior coverage compared to amoxicillin alone, with documented bacteriological eradication rates of 92.6% for H. influenzae and 98.4% for S. pneumoniae 1.
Monitor for common adverse effects including diarrhea (protocol-defined diarrhea occurs in 9-13% of patients), vomiting (6-7%), and diaper rash (6%) 1, 5.